• Olav M Andersen, Juliane Reiche, Vanessa Schmidt, Michael Gotthardt, Robert Spoelgen, Joachim Behlke, Christine A F von Arnim, Tilman Breiderhoff, Pernille Jansen, Xin Wu, Kelly R Bales, Roberto Cappai, Colin L Masters, Jørgen Gliemann, Elliott J Mufson, Bradley T Hyman, Steven M Paul, Anders Nykjaer, and Thomas E Willnow.
• Max Delbrueck Center for Molecular Medicine, D-13125 Berlin, Germany.
• Proc. Natl. Acad. Sci. U.S.A. 2005 Sep 20; 102 (38): 13461-6.

AbstractsorLA (Sorting protein-related receptor) is a type-1 membrane protein of unknown function that is expressed in neurons. Its homology to sorting receptors that shuttle between the plasma membrane, endosomes, and the Golgi suggests a related function in neuronal trafficking processes. Because expression of sorLA is reduced in the brain of patients with Alzheimer's disease (AD), we tested involvement of this receptor in intracellular transport and processing of the amyloid precursor protein (APP) to the amyloid beta-peptide (Abeta), the principal component of senile plaques. We demonstrate that sorLA interacts with APP in vitro and in living cells and that both proteins colocalize in endosomal and Golgi compartments. Overexpression of sorLA in neurons causes redistribution of APP to the Golgi and decreased processing to Abeta, whereas ablation of sorLA expression in knockout mice results in increased levels of Abeta in the brain similar to the situation in AD patients. Thus, sorLA acts as a sorting receptor that protects APP from processing into Abeta and thereby reduces the burden of amyloidogenic peptide formation. Consequently, reduced receptor expression in the human brain may increase Abeta production and plaque formation and promote spontaneous AD.

31 keywords...

hide…